UNSPSC 51422303: Betamethasone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9842X06Q6M, chemically known as 9-fluoro-11.beta.,17, 21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione but generally known as betamethasone, which bears US NIH Compound Identifier 3003.

Betamethasone comes in many forms, including base, acetate, acetate phosphate, acibutate, alcohol, benzoate, butyrate propionate, dihydrogen phosphate, dipropionate, disodium phosphate, phosphate, sodium, sodium phosphate, valerate, 17, 21-dipropionate, 17-acetate, 17 alpha-monopropionate, 17-benzoate, 17-dipropionate, 17-propionate, 17-propionate 21-methoxide, 17-valerate, 21-acetate, 21-disodium phosphate, 21-pentanoate, 21-phosphate, 21-phosphate disodium, and 21-valerate.

UNSPSC 51422303 Betamethasone is a Commodity code that nominally covers a specific corticosteroid pharmaceutical, but the single recent state-local opportunity tagged to this code does not align with the code's stated scope. Seminole County, Florida posted an IFB (Invitation for Bid) on June 30, 2026, soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually—neither of which are betamethasone or corticosteroid products. The mismatch suggests either a data-entry error in the county's tagging or a significant divergence between the code's nominal definition and how this particular jurisdiction classified the procurement. Without additional recent opportunities that actually reflect betamethasone purchases by state and local buyers, the code shows no meaningful activity in the market right now.

The Seminole County naloxone bid is the only recent opportunity in the source and does not support characterization of issuing-body patterns, geographic concentration, or typical scope under this code. Vendors responding to the Seminole County IFB must deliver quarterly shipments to the Seminole County Community Health Building in Sanford, Florida, include all shipping and delivery costs in their pricing, comply with E-Verify and drug-free workplace requirements, and maintain workers' compensation and professional liability insurance. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary period. Because the single posted opportunity lies outside the code's pharmaceutical scope, business development professionals should verify whether this code is actively used by state and local health agencies, pharmaceutical wholesalers, or school districts for actual betamethasone purchases before allocating pursuit resources.